Spire Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Sell
2,909
-2,963
-50% -$150K ﹤0.01% 881
2026
Q1
$313K Sell
5,872
-1,131
-16% -$66.4K 0.01% 660
2025
Q4
$435K Sell
7,003
-527
-7% -$32.5K 0.01% 572
2025
Q3
$452K Sell
7,530
-2,493
-25% -$152K 0.02% 554
2025
Q2
$628K Sell
10,023
-1,092
-10% -$65.6K 0.02% 460
2025
Q1
$669K Sell
11,115
-886
-7% -$55K 0.02% 493
2024
Q4
$700K Buy
12,001
+38
+0.3% +$2.26K 0.02% 478
2024
Q3
$708K Sell
11,963
-624
-5% -$35.6K 0.02% 452
2024
Q2
$705K Sell
12,587
-1,745
-12% -$97.7K 0.02% 420
2024
Q1
$840K Buy
14,332
+109
+0.8% +$6.16K 0.02% 413
2023
Q4
$788K Sell
14,223
-2,537
-15% -$124K 0.03% 414
2023
Q3
$813K Sell
16,760
-14,323
-46% -$762K 0.03% 377
2023
Q2
$1.75M Sell
31,083
-3,459
-10% -$191K 0.06% 254
2023
Q1
$1.86M Buy
34,542
+16,358
+90% +$871K 0.07% 234
2022
Q4
$956K Sell
18,184
-2,699
-13% -$137K 0.05% 238
2022
Q3
$985K Sell
20,883
-83,737
-80% -$4.34M 0.06% 213
2022
Q2
$5.28M Buy
104,620
+66,453
+174% +$3.62M 0.22% 118
2022
Q1
$2.33M Sell
38,167
-5,868
-13% -$350K 0.06% 245
2021
Q4
$2.9M Buy
44,035
+2,155
+5% +$138K 0.06% 254
2021
Q3
$2.63M Sell
41,880
-2,166
-5% -$138K 0.07% 241
2021
Q2
$2.65M Sell
44,046
-29,016
-40% -$1.68M 0.07% 241
2021
Q1
$3.99M Buy
+73,062
New +$4.05M 0.11% 182

Other funds holding IHI

Spire Wealth Management's IHI Position: Q2 2026 in Review

Spire Wealth Management reduced its iShares US Medical Devices ETF (IHI) stake by 50% in Q2 2026, selling an estimated $150K and leaving 2,909 shares worth $144K. The position accounts for ﹤0.01% of the portfolio, ranked #881.

Spire Wealth Management first reported a position in IHI in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.28M in Q2 2022. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Spire Wealth Management held 2,909 shares of iShares US Medical Devices ETF worth $144K as of Q2 2026.
  • Spire Wealth Management sold 2,963 iShares US Medical Devices ETF shares in Q2 2026, an estimated $150K.
  • iShares US Medical Devices ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #881 holding.
  • Spire Wealth Management first reported a position in iShares US Medical Devices ETF in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's iShares US Medical Devices ETF position peaked at $5.28M in Q2 2022.
  • 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.